Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity

We conducted a serological study to define correlates of immunity against SARS-CoV-2. Compared to those with mild coronavirus disease 2019 (COVID-19) cases, individuals with severe disease exhibited elevated virus-neutralizing titers and antibodies against the nucleocapsid (N) and the receptor bindi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Immunity
Main Authors: Ripperger, Tyler J., Uhrlaub, Jennifer L., Watanabe, Makiko, Wong, Rachel, Castaneda, Yvonne, Pizzato, Hannah A., Thompson, Mallory R., Bradshaw, Christine, Weinkauf, Craig C., Bime, Christian, Erickson, Heidi L., Knox, Kenneth, Bixby, Billie, Parthasarathy, Sairam, Chaudhary, Sachin, Natt, Bhupinder, Cristan, Elaine, El Aini, Tammer, Rischard, Franz, Campion, Janet, Chopra, Madhav, Insel, Michael, Sam, Afshin, Knepler, James L., Capaldi, Andrew P., Spier, Catherine M., Dake, Michael D., Edwards, Taylor, Kaplan, Matthew E., Scott, Serena Jain, Hypes, Cameron, Mosier, Jarrod, Harris, David T., LaFleur, Bonnie J., Sprissler, Ryan, Nikolich-Žugich, Janko, Bhattacharya, Deepta
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Inc. 2020
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7554472/
https://ncbi.nlm.nih.gov/pubmed/33129373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.immuni.2020.10.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados